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Integron gene cassettes 
harboring novel variants 
of d‑alanine‑d‑alanine ligase 
confer high‑level resistance 
to d‑cycloserine
Md. Ajijur Rahman1,2, Frank Kaiser1, Shirin Jamshidi3, Marta Freitas Monteiro1,6, 
Khondaker Miraz Rahman3, Peter Mullany1 & Adam P. Roberts4,5*
Antibiotic resistance poses an increasing threat to global health. To tackle this problem, the 
identification of principal reservoirs of antibiotic resistance genes (ARGs) plus an understanding of 
drivers for their evolutionary selection are important. During a PCR‑based screen of ARGs associated 
with integrons in saliva‑derived metagenomic DNA of healthy human volunteers, two novel variants 
of genes encoding a d‑alanine‑d‑alanine ligase (ddl6 and ddl7) located within gene cassettes in the first 
position of a reverse integron were identified. Treponema denticola was identified as the likely host of 
the ddl cassettes. Both ddl6 and ddl7 conferred high level resistance to d‑cycloserine when expressed 
in Escherichia coli with ddl7 conferring four‑fold higher resistance to D‑cycloserine compared to ddl6. 
A SNP was found to be responsible for this difference in resistance phenotype between the two ddl 
variants. Molecular dynamics simulations were used to explain the mechanism of this phenotypic 
change at the atomic scale. A hypothesis for the evolutionary selection of ddl containing integron 
gene cassettes is proposed, based on molecular docking of plant metabolites within the ATP and 
d‑cycloserine binding pockets of Ddl.
Globally, the emergence of antibiotic resistance in clinically important pathogens pose a significant threat to 
human health. Antibiotic resistance genes (ARGs) carried on various mobile genetic elements (MGEs), includ-
ing plasmids, transposons and integron gene cassettes (GCs) are responsible for the emergence, and worldwide 
dissemination, of multidrug-resistance. Identifying the principal reservoirs of  ARGs1,2 as well as understanding 
the drivers for their evolutionary selection and  spread3 are fundamental to tackling the problem of antibiotic 
resistance.
Integrons are genetic elements capable of capturing and expressing open reading frames (ORFs) embedded 
in GCs. They are well known for their role in dissemination of ARGs particularly in gram-negative pathogens. 
The basic structure of an integron is composed of a gene (intI) encoding a DNA integrase, an integron associ-
ated recombination site; attI and a gene cassette promoter (Pc), which expresses the inserted cassettes within 
the GC array. Usually the integron integrase gene and the genes in the GC array are divergently transcribed, 
however where the integrase and the GC array are transcribed in the same direction the integron is known as 
a “reverse integron”4,5. The integron integrase (IntI) catalyses recombination between the cassette associated 
recombination site; attC and the attachment site; attI, within the integron  platform6–8. More than 130 MGE 
associated ARGs have been detected in integrons, conferring resistance to most classes of antibiotics including 
aminoglycosides, chloramphenicol, beta-lactams, trimethoprim and  streptothricin9,10. Integrons carry ARGs, 
plus other genes encoding proteins with more diverse functions including adaptation to stress, virulence and 
resistance to xenobiotics, and many, particularly those integrons located on chromosomes, encode proteins of 
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unknown  functions5. For instance, among the 70 ORFs detected within 47 gene cassettes in the chromosomal 
integron of Treponema denticola11, an oral pathogen associated with periodontitis, only five ORFs matched with 
proteins of known functions (last confirmed August 2019).
This article reports the detection of two novel reverse integron-located genes encoding D-alanine-D-alanine 
ligases (Ddls). Ddls are ATP-dependent enzymes that play a critical role in the synthesis of peptidoglycan during 
the cytoplasmic stage by catalysing the formation of the d-ala-d-ala dipeptide required for cross-linking pepti-
doglycan strands during cell wall  synthesis12. The gene encoding Ddl is a housekeeping gene and has always been 
found in the chromosome, never in a MGE. The formation d-Ala-d-Ala dipeptide catalysed by Ddl is critical for 
bacterial  growth13,14. As there is no human homologue, Ddl is considered an excellent target for designing new 
 antibiotics15. d-Cycloserine is the only inhibitor of Ddl used in the  clinic13, however, due to the severe neurologic 
side effects, its use is currently reserved for the treatment of multidrug resistant (MDR) and extensively-drug 
resistant (XDR)  tuberculosis16,17.
We demonstrate d-cycloserine resistance associated with these integron located ddls and present an experi-
mentally supported hypothesis as to why ddl, a housekeeping gene, has evolved to be on an integron gene cassette.
Results
Two novel variants of ddl were discovered from the human oral cavity located immediately 
downstream of the core structure of a reverse integron. During a PCR screen for the presence 
of integron GCs carrying ARGs in the saliva-derived metagenomic DNA of healthy volunteers from the UK 
(n = 11) and Bangladesh (n = 12), two natural variants of ddl located within the first GC of a reverse integron 
were discovered. In the libraries of PCR amplicons of integrons and associated GCs, a total of five clones (three 
from the UK and two from Bangladesh) were recovered carrying ddl predicted to encode a d-alanine-d-alanine 
ligase. Among the three ddl-carrying clones obtained from UK metagenomic libraries, one clone carried ddl6 
and two clones carried ddl7 and among the two clones obtained from BD library, one clone carried ddl6 and 
another clone ddl7.The genetic organisation of the ddl inserts in the clones are shown in Fig. 1A. The intI and 
the ddl gene cassettes are oriented in the same direction in reverse integrons (where the integrase is orientated 
in the opposite direction compared to usual integrons) of T. denticola11. Two putative integrase binding sites [L 
or S2 and R or S1], two direct repeat sequences (DR1 and DR2) and a putative attI/attC recombination site were 
detected (Fig. 1B). The stop codon of the ddl ORF was located on the 7 bp attC core site, R″ (Fig. 1C). The R″ site 
is followed by the L″ site-which covers the priming site of the reverse primer MARS2.
Two variants of ddl (named as ddl6 and ddl7) were different from each other by two SNPs at c.490 and c.777 
positions of the coding sequences of the genes. The CTT (Leu164) and TGG (Trp259) codons of ddl6 were sub-
stituted with TTT (Phe164) and TGT (Cys259) in ddl7, respectively.
The closest homologue of ddl6 and ddl7 is a ddl located within the accessory genome of T. 
pedis B683. The closest homologue of the cassette-located ddls having 98% nucleotide sequence identity 
(97% identity at the amino acid level) was located on a 5699 bp contig of T. pedis B683 genome (GenBank acces-
sion: NZ_AOTN01000179) containing a total of six ORFs (Fig. 1D). This homologous ddl of T. pedis, named 
ddl(GC), was flanked by two attC recombination sites. The sequences of the core sites (R″ and L″) of attC located 
downstream of ddl(GC), were 100% identical with the corresponding sites of attC located downstream of ddl6 
and ddl7 (Fig. 1D). Another attC was found upstream of ddl(GC) flanking two ORFs encoding hypothetical 
proteins (Fig. 1D). However, as there was no integrase gene, the association of this contig with an integron, 
although likely, could not be confirmed. The next closest homologue was Ddl of Syntrophobotulus glycolicus 
(ADY55260) with 55% amino acid identity, followed by Clostridium sp. (54%; WP_033164556), Lachnoclostrid-
ium phytofermentans (53%, WP_029502590) and Paenibacillus pini (52%; WP_036650467). Ddl proteins with 
altered specificity that confer resistance to vancomycin such as VanA (AAA65956), VanB (YP_009076352) and 
VanC (P29753) also shared low sequence identity (27 to 30%) with Ddl6 and Ddl7.
T. pedis B683 carries two ddl genes, one of which (GenBank accession: AOTN01000124: 8689-9912 bp) 
is most likely the house-keeping ddl as it is found in other strains of T. pedis including TA4 and TM1 and its 
Figure 1.  Features of the ddl gene cassettes, their closest homologues and the phylogenetic analysis. (A) 
Genetic organisation of 2024 bp inserts in the pGEM-T Easy vector; (B) Comparison of putative attI sequence 
preceding ddl in the inserts with the putative attI of the integron of T. denticola ATCC  3540511. The putative 
integrase binding sites S1 and S2 as well as DR1 and DR2 are also shown. The putative recombination point 
G↓TT and the putative transcription start site (TSS) located at the 3ʹ-end of attI are also shown. (C) Comparison 
of partial sequence of attC detected at the 3ʹ-end of the 2024 bp insert with a typical complete attC-associated 
with Tde1837 of T. denticola  integron11. (D) The percentage identity of the flanking sequence of ddl6/ddl7 (40 bp 
upstream and 29 bp downstream) with their closest homologue, ddl(GC) located on a 5699 bp contig of T. pedis 
B683 genome (GenBank accession: NZ_AOTN01000179). The putative core sites of the attC (R″ and L″), the 
simple integrase binding site (S1) are shown. The recombination points located on S1 and core site, R′ of the attC 
located upstream of ddl(GC) (attCHDIG) are marked with the blue arrows. The binding sites for the primers, TDIF 
and MASRS2, used for amplification of the integrons and associated gene cassettes are also shown. The start 
codons (ATG) as well as the S1, R′, R″, L″ sites are in bold. (E) Phylogenetic tree of ddl6, ddl7 and ddl(GC) along 
with the ddls of different strains of T. denticola and other Treponema species. The ddlA of E. coli was used as an 
outgroup. The evolutionary relationship was inferred using the Neighbour-Joining  method18. The percentage 
of replicate trees in which the associated taxa clustered together in the bootstrap test (500 replicates) are shown 
next to the branches. Evolutionary analyses were conducted in MEGA  X19.
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G+C content (38.0%) is similar to the genome of T. pedis B683 (36.9%). In contrast, the G+C content of the GC 
located ddl is 30.6% suggesting that this second, cassette-located ddl may have been acquired by horizontal gene 
transfer by T. pedis B683.
Comparative genomics shows that a likely horizontal gene transfer (HGT) occurred between 
the T. pedis B683 and the host of ddl6 and ddl7. The following three observations suggested HGT 
between T. pedis B683 and the host of ddl6/ddl7: (i) The identical 40 bp sequences upstream of ddl6/ddl7 and 
their homologue ddl(GC); (ii) the nearly identical (90%) 29 bp downstream sequences containing R″ and L″ sites 
of attC (Fig. 1D); (iii) the phylogenetic tree constructed using the ddls of different species of Treponema showed 
that the integron-located ddl6 and ddl7 and ddl(GC) formed a separate clade within the tree (Fig. 1E).
Sequence of the upstream region of the integron carrying ddl7 suggests that the putative 
host of the integron carrying ddl6 and ddl7 is a strain of T. denticola. To confirm if the initially 
Figure 2.  The genetic arrangement of 4421 bp pGEM-T Easy insert carrying ddl7, full length intI and another 
partial ORF encoding a hypothetical protein. The primers used to amplify this product are shown with small 
arrows. The genetic arrangements of the closest homologues including T. denticola H-22 (GenBank accession: 
AGDV01000005:c23656-19631), T. denticola ATCC35405 (Genbank accession: AE017226:1873126-1877351) 
and T. denticola US-Trep acdtB (GenBank accession: AGEB01000014.1:3405-5167) have also been shown. 
The most variable region among the strains was found to be the sequence between the ORF for a hypothetical 
protein (Hyp. Protein in the top row) and intI.
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recovered 2024 bp PCR amplicons were obtained from the T. denticola genome, sequence of the intI that was 
further upstream was amplified by PCR. Analysis of a 4421 bp PCR product showed that it contained a partial 
ORF encoding a hypothetical protein (1–1362 bp), a complete ORF encoding IntI (1266 bp: 1925–3191 bp), a 
putative attI, the Pc promoter followed by a GC carrying ddl7 (3389–4421 bp) (Fig. 2). The complete intI had 
96.0% nucleotide identity with intI of T. denticola H-22 (GenBank accession no: AGDV01000005:19792-21072). 
At the amino acid level, the identity ranges between 81 and 97% with IntI of different Treponema sp. Maximum 
identity was found with the IntI of T. denticola AL-2 (97%, EMB42956).
The genetic organisation of the 4421 bp amplicon was different from the closely related hits in the NCBI 
databases (Fig. 2). The non-protein-coding 556 bp sequence located between the partial ORF and the intI har-
bors the putative promoter for the intI (Pint) with a sequence of 5′-ATG AAT |19 bp| TAA ACT -3′. The upstream 
sequence of the intI was analyzed in silico for potential LexA binding sites similar to that found in the upstream 
of intI of mobile and chromosomal  integrons20. However, no LexA binding motif could be detected. Addition-
ally, this region contains several inverted repeat and direct repeat sequences as well as a putative transcriptional 
terminator sequence.
A phylogenetic tree was constructed to compare the evolutionary relationship of intIs associated with the 
integron carrying ddl with the intIs of different species of Treponema. The tree showed that the intI associated 
with ddl7 is closely related with other intIs of T. denticola and distantly related to T. pedis (Supplementary Fig. S1). 
The results obtained from the intI tree as well as the identity of the upstream sequence intI with the other strain 
of T. denticola suggest that the likely host of the integron associated with ddl7 is a species of the genus Treponema 
and most likely a strain of T. denticola.
Expression of ddl6 and ddl7 confers resistance to D‑cycloserine only, not to vancomycin and 
beta‑lactams. As the overexpression of ddl of M. tuberculosis and M. smegmatis was found to confer 
D-cycloserine  resistance21, we hypothesised that the expression ddl6 or ddl7 in an integron array will result in 
d-cycloserine resistance, especially as they are detected in the first position due to the efficient expression by 
the Pc. When the minimum inhibitory concentrations (MIC) of d-cycloserine against the surrogate E. coli hosts 
EC126 and EC127 carrying pGEM-T Easy::intI-attI-ddl6 and pGEM-T Easy::intI-attI-ddl7, respectively were 
tested, a two to four-fold increase of MIC of d-cycloserine was observed (Table 1). As the upstream region of 
ddl6 and ddl7 cassettes carrying the attI and Pc were 100% identical, we concluded that the fourfold change in 
the MIC was due to either the SNP c.490 or c.777 or both.
To determine if the overexpression of ddl in gram-positive bacteria can also confer resistance to d-cycloserine, 
vancomycin and β-lactam antibiotics, the 1032 bp coding sequence of ddl6 and ddl7 was cloned into a medium-
copy expression vector, pHCMC05 and transformed into B. subtilis 168. The MIC of D-cycloserine against the 
strains BS706 and BS707 which carry pHCMC05::ddl6 and pHCMC05::ddl7 vectors, respectively was found 
to increase by eight-fold (64 µg/mL) compared to the BS700 strain that carries the empty plasmid (8 µg/mL) 
(Table 1). However, no difference in the MIC of D-cycloserine was observed between BS706 and BS707 carrying 
ddl6 and ddl7, respectively, when the expression of the genes was induced by IPTG. No resistance to vancomycin 
was observed (Table 1). Nor was there any resistance to penicillin G, amoxicillin, oxacillin and ampicillin against 
both E. coli and B. subtilis strains. This suggests that overproduction of Ddl does not confer cross-resistance to 
antibiotics targeting cell-wall biosynthesis.
Site‑directed mutagenesis confirmed that the SNP at c.777 was responsible for the alteration 
of MIC of d‑cycloserine. To identify which SNP of ddl6 and ddl7 was responsible for altering the suscep-
tibility of E. coli to d-cycloserine, the nucleotides at position c.490 and c.777 of ddl6 were changed to the cor-
responding nucleotides of ddl7 by site-directed mutagenesis. MICs of d-cycloserine against E. coli carrying the 
constructs were determined and no change in the susceptibility was observed by the c.490 C>T substitution in 
Table 1.  MIC of D-cycloserine against different strains of E. coli and B. subtilis expressing ddl. ND not 
determined.
Bacterial strain Plasmid vector Inserts and their size MIC of D-cycloserine (µg/mL) MIC of vancomycin (µg/mL)
E. coli ɑ-select
EC121 pGEM-TEasy Empty (vector control) 8 ND
EC126 pGEM-TEasy intI-attI-ddl6 (2024 bp) 16 ND
EC127 pGEM-TEasy intI-attI-ddl7 (2024 bp) 64 ND
EC206 pGEM-TEasy intI-attI-ddl6 c.490 C > T (2024 bp) 16 ND
EC207 pGEM-TEasy intI-attI-ddl6 c.777G > T (2024 bp) 64 ND
B. subtilis 168
BS700 pHCMC05 Empty (vector control) 8 < 0.125
BS706 pHCMC05 pHCMC05:: ddl6 64 < 0.125
BS707 pHCMC05 pHCMC05:: ddl7 64 < 0.125
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ddl6, however, the G>T substitution which alters Trp259 to Cys259 (W259C) increased the MIC fourfold which 
is similar to the MIC of the strain carrying ddl7 (Table 1).
The integron‑encoded Ddls are functional. The biological activity of Ddl6 and Ddl7 was confirmed 
using purified proteins (Fig. 3A). The release of the inorganic phosphate (Pi) in the Ddl-catalyzed reaction was 
assayed and both variants of Ddl catalyse the release of a significant amount of Pi into the reaction compared to 
the control (P > 0.05) (Fig. 3B). This indicates that ATP is consumed in the reaction and Pi is released. Further-
more, paper chromatography analysis of the Ddl-catalysed reaction product showed that both proteins catalyze 
Figure 3.  Purification of Ddl and determination of the functional activity Ddl. (A) SDS-PAGE of purified 
Ddl6 and Ddl7. (B) Release of inorganic phosphate in the reactions catalysed by Ddl6 and Ddl7 in the 
presence of 20 mM D-alanine. The differences of the release of Pi in between the negative controls (no Ddl) 
and Ddl catalysed reactions were analysed by one-way ANOVA (***P < 0.001; ***P < 0.0001). (C) Ascending 
paper chromatography to detect the formation of d-ala-d-ala and d-ala-d-ser dipeptide as well as d-ala-d-
lac depsipeptide. In the first two reactions (lane 1 and lane 2) 20 mM d-alanine was used, whereas in other 
reactions it was reduced to 10 mM and supplemented with 10 mM d-serine or d-lactate.
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the ligation of d-ala resulting in the synthesis of d-ala-d-ala dipeptide (Fig. 3C). The substrate specificity assay 
indicated that they could only catalyse the synthesis of d-ala-d-ala dipeptide, and not d-ala-d-ser or d-ala-d-lac.
The predicted 3D structures of Ddl6 and Ddl7 provided information on alteration of resistance 
phenotype and substrate specificity. To determine if the alteration of Trp259 of Ddl6 to Cys259 of 
Ddl7 caused a conformational change, 3D models of both Ddl6 and Ddl7 were constructed using I-TASSER22 
(Supplementary Fig. S2). When the structures were superimposed using TM-align23, they superimpose near 
perfectly with a TM score of 0.97. However, a notable predicted change in the conformation of the omega-loop 
region was observed likely resulting from the substitutions at 164 and 259 positions of Ddl6 and Ddl7 (Supple-
mentary Fig. S3).
Three putative domains of Ddl6 and Ddl7 were identified by comparing predicted 3D structures of Ddl6 and 
Ddl7 with the crystal structure of D-ala-D-ser ligase (VanG, PDB code: 4FU0)24, DdlB of E. coli25, VanA of E. 
faecium26 and Ddl of S. aureus27. The predicted N-terminal domain of Ddl6 and Ddl7 runs from the N-terminus 
to Gly125, central domain from Ser126 to Gly219 and C-terminal domain from Arg220-Ile340. The putative 
omega-loop, which plays an important role in catalytic activity and substrate specificity of Ddl proteins, was 
located on the C-terminal domain of Ddl6 and Ddl7 and runs from Lys240-Ser255. The Trp259 of Ddl6 whose 
substitution with Cys259 causes a fourfold increase in D-cycloserine resistance was found to be located at the 
end of the 4th β-sheet (residues Asn256-Ile258) of the C-terminal domain and outside of the omega-loop (Sup-
plementary Fig. S2). The amino acid residues (Ser150 and Tyr216) of E. coli DdlB which are conserved in the 
Ddls that can only produce D-ala-D-ala residues were also conserved in Ddl6 and Ddl7 with the correspond-
ing residues of Ser184 and Tyr250 (Supplementary Fig. S4).This supports the results of the in-vitro assays and 
explains why it could produce only the d-ala-d-ala dipeptide, not d-ala-d-ser or d-ala-d-lac.
Although the integron-encoded Ddls were not found to confer vancomycin resistance and did not carry the 
amino acid residues for altered substrate specificity (d-Ser or d-Lac), among the closest homologues in PDB 
that matched with the predicted 3D structures of Ddl6 and Ddl7, four were related to vancomycin resistance 
including VanG (PDB code: 4FU0) and VanA (PDB code: 1E4E) with high TM scores (Supplementary Table S1).
Molecular dynamics simulations post‑analysis provides insights into the mechanism of altera-
tion of MIC of d‑cycloserine due to W259C mutation in Ddl6. The results of 50 ns molecular dynam-
ics (MD) simulations of wild-type Ddl6 and its W259C mutant derivative in complex with d-cycloserine (Fig. 4) 
showed that the ligand is released from the recombinant protein after approximately 20 ns, however, the complex 
with the wild-type protein remains stable in the binding site during the course of the MD simulations.
The movement of the ligand from the protein was studied by monitoring the distances (Supplementary 
Fig. S4) between the centre of d-cycloserine and Trp259 of the wild-type Ddl6 and Cys259 of the Ddl6 W259C 
mutant during the course of the simulation. The distance between the centre of d-cycloserine and Cys259 of the 
mutant protein progressively increased suggesting a movement away from the binding site, whereas the distance 
between the centre of d-cycloserine and Trp259 of the wild-type protein remained relatively stable throughout 
the simulation (Supplementary Fig. S5).
The relative binding free energy values calculated from the MD simulations trajectories further supported 
this observation as the complex of wild-type Ddl6 and d-cycloserine was more favorable (− 14.47 kcal/mol) than 
the complex of d-cycloserine and Ddl6 W259C mutant complex (− 12.15 kcal/mol) (Supplementary Table S2). 
Videos of the MD simulations showing the movement of the ligands are available in Supplementary Video S1 
and Video S2.
Kinetic analysis of pure proteins showed that Ddl7 is more active than Ddl6. The integron-
encoded Ddl6 and Ddl7 were characterised kinetically and the kinetic parameters were compared with DdlTd 
(the Ddl encoded by housekeeping ddl of T. denticola) and DdlAEc as positive control. The  Km,d-ala2 of Ddl6 and 
Ddl7 was determined as 0.39 and 0.54 mM, respectively (Table 2), thus, the values of  Km,d-ala2 could not explain 
the alteration of D-cycloserine phenotype between these two variants. However, the turnover number  (Kcat) of 
Ddl7 (3.85 s−1) was approximately three-fold higher than Ddl6 (1.20 s−1), which nearly matches the fourfold 
increase of MIC of D-cycloserine for Ddl7 as compared to Ddl6.
Molecular docking analysis showed that flavonoids could be responsible for selection of the 
ddl6/ddl7 within the first position of the integron. We also tried to identify the likely selection pres-
sure that could drive the evolution of ddls within integrons and maintain them as the first GC. As the use of 
D-cycloserine is restricted only for the MDR and XDR Mycobacterium tuberculosis, it is very unlikely to be 
responsible for this. We assumed that this selective pressure is common for both countries from which ddl con-
taining strains were isolated (Bangladesh and the UK), as the ddls were ubiquitous within samples from both 
geographic locations. Candidates for providing this selective pressure are two plant flavonoids, quercetin and 
apigenin, which are abundantly present in many teas, fruits and vegetables and inhibit  Ddl29. Molecular docking 
was used to see if these flavonoids can bind to Ddl within the predicted D-alanine and/or ATP binding sites of 
Ddl6 and Ddl7. Salvicine (a terpenoid isolated from a Chinese medicinal plant, Salvia prionitis) was used as a 
positive control for the docking because this terpenoid was previously identified as a potent inhibitor of Ddl of T. 
pallidum using molecular  docking30. GOLD molecular docking showed that quercetin and apigenin can dock to 
both d-alanine (Fig. 5; Supplementary Table S3) and ATP binding sites (Supplementary Fig. S6; Supplementary 
Table S3) of Ddl6 and its mutants therefore, the integron-encoded Ddls may play a role in both the sequestration 
of these inhibitors, lowering the intracellular concentration and allowing the house-keeping Ddl to perform its 
physiological functions and also take on the role of the house-keeping Ddl during cell wall development.
8
Vol:.(1234567890)
Scientific Reports |        (2020) 10:20709  | https://doi.org/10.1038/s41598-020-77377-4
www.nature.com/scientificreports/
Figure 4.  2D (right panels) and 3D (left panels) structures of the binding sites of the W259C mutant of 
Ddl6 (a) and wild-type Ddl6 (b) in interaction with d-cycloserine in average structures extracted from MD 
trajectories. After placing in the same location at the beginning of the MD simulations, both ligands were found 
in the adjacent grooves in the same binding site of their corresponding average structures.
Table 2.  Steady-state kinetic parameters of Ddl6, Ddl7, DdlTd and DdlEc. *The values of DdlAEc reported by 
Zawadzke, et al.28. NR not reported.
Proteins Km, ATP (µM) Kcat  (s−1) Km, d-ala2 (mM) Kcat/Km, d-ala2  (M−1 s−1)
Ddl6 54.96 1.19 0.39 3008.85
Ddl7 43.28 3.85 0.55 7010.32
DdlTd 19.08 3.74 0.45 8294.55
DdlAEc 48.99 6.43 0.52 12,517.21
DdlAEc* 38* NR 0.55* NR
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Discussion
This study reports for the first time the discovery of integron GCs encoding two novel isoforms of Ddl (Ddl6 and 
Ddl7) derived from the oral cavity microbiota of healthy humans in the UK and Bangladesh. The ORFs encoding 
Ddl were located immediately downstream of intI on reverse integrons. All of the genetic characteristics of an 
integron and its associated GCs were found within the amplicon, including the presence of a putative Pc, an attI 
region harbouring putative integrase binding sites (S1 and S2), a putative attI/attC recombination site, a putative 
RBS located 6-bp upstream of the start codon of the ddls as well attC core sites (R″ and L″)6,7,10,31.
The closest homologue of ddl6 and ddl7 with approximately 98.0% nucleotide identity was located on a 
whole genome sequence (WGS) contig of T. pedis B683 and is one of two copies of ddl within this genome 
and is not present in the genome of other T. pedis strains, thus it is likely part of the accessory genome. T. pedis 
is an animal pathogen that causes digital dermatitis in cattle and necrotic ulcers in  pigs32. B683 (GenBank 
(NZ_AOTN00000000.1) was isolated from a shoulder ulcer of a pig. The evidence showed that there is a likely 
genetic exchange between T. pedis and the host of ddl6/ddl7, likely to be T. denticola, which may involve one or 
more transfer intermediates.
Analysis of the upstream sequence of the integron carrying ddl6/ddl7 suggests that the likely host of the inte-
gron is a strain of T. denticola which carries two copies of ddl in its genome: one as an integron GC and another as 
house-keeping gene (this house-keeping ddl of T. denticola ATCC35404 showed only 46.0% nucleotide identity 
to ddl6 and ddl7). T. denticola is one of the most comprehensively characterised species among the 49 species of 
Treponema in the human oral  cavity33. It is one of the members of the ‘red complex’ associated with clinical pro-
gression of  periodontitis34 and is capable of transferring genes to different genera of bacteria in dental  plaque35. It 
is the only bacterial species in the oral cavity that has been found to carry  integrons11 although we have recently 
demonstrated other bacterial species are also likely to contain  integrons36. From the in silico analysis of the 
metagenomic datasets of the NIH Human microbiome project, a total of 826 gene cassettes related to Treponema 
Figure 5.  Mode of interaction of apigenin and quercetin with the d-alanine binding sites of wild-type Ddl6 and 
its W259C mutant. (A) Apigenin with wild-type Ddl6, (B) Apigenin with W259C mutant, (C) Quercetin with 
wild-type Ddl6 and (D) Quercetin with W259C mutant.
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sp. were detected in the oral  cavity37. The closely related strains of T. denticola shared a high nucleotide identity 
(> 80%) of their integron gene  cassettes38.
Our results provide novel insights into the evolutionary mechanisms that have facilitated the acquisition of 
a second copy of ddl on an integron in the original host of ddl6 and ddl7. Zawadzke et al.28 proposed multiple 
explanations for the duplication of ddl seen in E. coli however these are likely not applicable here because, unlike 
the duplicated ddlA and ddlB genes of E. coli, the ddl cassettes described here are likely to have been acquired 
by HGT and thus, they may be related to gaining a new function (resistance to antimicrobial compounds) in 
addition to, or rather than, providing increased amount of the gene  product28,39. The kinetic analysis of the 
purified proteins (Ddl6, Ddl7 and DdlTd) also indicates that the ddls are interchangeable with respect to their 
core function of cell wall assembly because, the  Kcat  (s−1) of DdlTd was very close to Ddl7 thus, the acquisition 
of a second copy of ddl within integrons provide resistance by titrating out intracellular antimicrobials plus 
complementation of the original Ddl function.
We found that the ectopic expression of ddl6 and ddl7 confers resistance to d-cycloserine. As Ddl is a target 
of d-cycloserine, overproduction of Ddl is likely to facilitate resistance by mechanisms similar to D-cycloserine 
resistance in Mycobacterium which is mediated by high expression of both Ddl and  Alr21,40. The other known 
mechanisms of D-cycloserine resistance in Mycobacterium were the non-synonymous mutations in Alr includ-
ing S22L, K133E, L89R, M319T, Y364D and  R373G41,42 as well as loss of function mutation in alr42. In E.coli the 
mutation in cycA43, dadA and pnp44 confer resistance to d-cycloserine. The mutations in a penicillin binding 
protein (PBP4) homologue in M. smegmatis confer resistance to d-cycloserine and  vancomycin45. Although sev-
eral mutations in alr have been implicated in d-cycloserine resistance, so far no mutations in ddl were found to 
be associated with alteration of d-cycloserine resistance by the host. Moreover, several functional metagenomic 
analyses reported that ectopic expression of various ddl also conferred resistance to d-cycloserine46–49.
While the expression of both integron encoded ddls conferred resistance to d-cycloserine, the expression of 
ddl7 had a four-fold higher MIC compared to ddl6. Site-directed mutagenesis confirmed that a single substitu-
tion at c.777, which alters Trp259 of Ddl6 to Cys259, was responsible for this. Using MD simulations, we have 
shown how this mutation is predicted to alter the binding affinity of the ligand d-cycloserine to the active sites 
of the proteins. The wild-type Ddl6 with a tryptophan residue at its 259-position had more stable binding to 
d-cycloserine, therefore less d-cycloserine would be required to occupy active sites which in turn will decrease 
the MIC. When the aromatic, non-polar, hydrophobic tryptophan residue was changed to polar, thiol  reactive50 
and disulphide bridge  forming51 cysteine (the residue at 259 for Ddl7), binding between the mutant Ddl6 and 
d-cycloserine complex was comparatively less stable and thus, more antibiotic will be needed to occupy the active 
sites which causes an increase in the MIC.
Four of the closest structural homologues of Ddl6/Ddl7 were related to vancomycin resistance including 
VanA of E. faecium, and VanG of E. faecalis. It is known that the function of a protein is more related to the 
structure rather than the  sequence52. The inclination of the predicted 3D structures of Ddl6 and Ddl7 towards 
vancomycin resistant determinants suggests that if the corresponding residues of VanG or VanA, which are 
responsible for binding and positioning d-ser (VanG-type) or d-lac (VanA-type) instead of d-ala2, are substituted 
to the corresponding residue of Ddl6 and Ddl7 (Tyr250), they could gain d-ala-d-ser dipeptide or d-ala-d-lac 
depsipeptide ligase activity. The E. coli DdlB gained a weak d-ala-d-lac depsipeptide activity following Tyr216 
and Ser150 substitutions with phenylalanine and alanine of  LmDdl253, respectively supporting our hypothesis.
We also suggest a hypothesis for evolution of ddl within an integron cassette at the first position. d-Cycloserine 
is currently only used in the treatment of MDR and XDR-tuberculosis54 and there is no history of environmental 
use of d-cycloserine in agriculture. Additionally, none of the volunteers received this drug (or any other anti-
biotic), at least in the three months prior to saliva collection. Therefore, it is very unlikely that d-cycloserine 
represents the driving force for this event. We hypothesize that dietary flavonoids or other inhibitory small 
molecules present in our diet that can bind Ddl drive the acquisition and selection of ddl within integrons. Some 
flavonoids including apigenin, quercetin and catechin are known to have antibacterial  activity55,56 and are found 
in fruits and vegetables as well as widely consumed beverages such as tea. Apigenin and quercetin has been 
shown to inhibit the activity of Ddl of H. pylori by competitively inhibiting the binding of ATP to ATP-binding 
 sites29,57. MD analysis performed in this study supported the findings and demonstrated that these flavonoids 
are likely to bind to both d-ala and ATP binding sites of Ddl6 and Ddl7. Thus, the excess Ddl produced by the 
efficient expression under the control of Pc could confer a selective advantage on the host titrating out inhibitory 
flavonoids (Fig. 6). This hypothesis requires testing experimentally which is now under way.
The results show that ddl, which is generally considered a housekeeping gene has moved onto an integron 
and can be found in the first position, with the most likely selection pressure being dietary compounds with 
antimicrobial activity. Because these genes also confer resistance to d-cycloserine and are potentially one muta-
tion away from vancomycin resistance, the study also sheds light on potential environmental drivers of clinically 
relevant antimicrobial resistance.
Materials and methods
Source of chemicals, reagents and antibiotics. Chemicals, solvents, culture media and antibiotics 
were purchased from Sigma-Aldrich Ltd (Dorset, UK), BDH (UK) and Life Technologies (USA) unless stated 
otherwise. Plasmid preparation kits were obtained from Qiagen (UK). Restriction enzymes were obtained either 
from New England Biolabs (UK) Ltd or from Promega (UK). The EnzChek Phosphate assay kit and Pierce BCA 
Protein assay kits were purchased from Life Technologies (USA). E. coli α-Select competent cells were obtained 
from Bioline Reagents Ltd (UK). The primers were obtained from Sigma-Aldrich (UK).
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Bacterial strains and plasmids. The pGEM-TEasy vector (Promega) was used for constructing the 
metagenomic library of PCR amplicons of integrons and gene cassettes. E. coli α-select silver efficiency (Bioline) 
was used to manipulate the pGEM-TEasy library of gene cassettes. pET28a (Novagen) and E. coli BL21 (DE3) 
(New England Biolabs) were used for cloning and expression of ddls and purification of corresponding His-
tagged proteins, respectively. Bacillus subtilis 168 and pHCMC05 (Bacillus Genetic Stock Centre) were used for 
cloning and expression of ddl6 and ddl7 to determine the susceptibility of D-cycloserine and vancomycin in 
Gram-positive bacteria. E. coli strains were cultured in LB medium at 37 °C. Bacillus subtilis 168 was cultured in 
Brain–heart infusion (BHI) medium unless stated otherwise. The bacterial strains were preserved at − 80 °C in 
30% (v/v) sterile glycerol.
Detection of ddl gene cassettes in the metagenomic DNA obtained from saliva. The collection 
of saliva samples, preparation of metagenomic DNA from pooled saliva from UK and Bangladesh and detec-
tion of integrons and gene cassettes in the library PCR amplicons have been described  previously36. Primers 
for reverse integrons were utilized as PCRs using primers to detect integrons failed to yield amplicons from 
metagenomic  DNA36. Ethical approval was obtained from University College London (UCL) Ethics Committee 
(project number 5017/001) and the Institutional Animal, Medical Ethics, Biosafety and Biosecurity Committee 
(IAMEBBC) for Experimentations on Animal, Human, Microbes and Living Natural Sources, University of 
Rajshahi (project number 54/320/IAMEBBC/IBSC). All volunteers provided informed consent and all proce-
dures were carried out according to relevant guidelines and regulations. Briefly, the PCR products produced 
using the forward integrase primer (TDIF) and reverse attC-based primer (MARS-2) were cloned into pGEM-
TEasy and transformed into E. coli alpha select cells. Transformants were randomly picked, plasmids were pre-
pared from 5 mL overnight culture using Miniprep kits (Qiagen) and the plasmids were sequenced using M13F-
M13R primers (Supplementary Table S4).
Determination of the upstream region of integron carrying ddl6 and ddl7. A total of four dif-
ferent forward primers (Upint_5100F, Upint_3685F, Upint_721F, Upint_122F) (Supplementary Table S4) were 
designed randomly at different locations upstream of the intI gene of the chromosome of T. denticola ATCC35405 
(NC_002967.9). PCR was performed by combining these primers with the reverse primer, ddlR designed from 
the 3′-end of ddl6/ddl7. It was assumed that if the integrons carrying ddl GCs are located on the chromosome of 
T. denticola, the PCR products will yield a different length of upstream region of intI.Q5 High-Fidelity 2X Master 
Mix (NEB, UK) was used for PCR using the pooled metagenomic DNA of UK saliva samples as template. The 
reaction condition for PCR was as follows: an initial denaturing temperature of 98 °C for 30 s followed by 30 
cycles at 98 °C for 10 s (denaturing), 50–58 °C for 30 s (annealing), and 72 °C for 200 s (extension). The PCR run 
Figure 6.  Proposed model for plant flavonoids promoting the selection of ddls and their maintenance within 
the first GC of the integron of T. denticola. The integron encoded Ddl6/Ddl7 could play a dual role (marked with 
asterisk): sequestration of flavonoids or other molecules that are able to bind Ddl and catalysing the formation of 
d-ala-d-ala dipeptide in presence of inhibited Ddl encoded by the housekeeping genes.
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ended with a final 72 °C elongation step for 10 min before holding the reaction at 4 °C. The expected size PCR 
products were purified by gel extraction using QIAquick Gel Extraction Kit (Qiagen, Germany) and A-tailed fol-
lowing the protocol for cloning blunt-ended PCR products described in pGEM-T Easy Vector Systems Technical 
Manual (Promega, UK). A 30 µL reaction mixture for A-tailing contained about 30 ng purified PCR product, 
3 µL of 10 × standard Taq reaction buffer, 1.5 µL 100 mM dATP, 2 µL Taq DNA polymerase (NEB, UK) and 
molecular grade water up to 30 µL. The reaction mixture was then incubated for 30 min at 72 °C in a block of 
PCR machine. An aliquot of A-tailed PCR products was cloned into pGEM-T Easy and then transformed into 
E. coli alpha select cells. The transformants were selected on LB agar plates supplemented with ampicillin, IPTG 
and X-gal. Plasmids were prepared and the inserts were sequenced.
Site‑directed mutagenesis. The Phusion Site-Directed Mutagenesis Kit (Thermo Scientific, USA) 
was used to construct two different mutants of ddl6: ddl6 c.490 C>T and ddl6 c.777 G>T using the pGEM-
TEasy::intI-attI-ddl6 plasmid as template. The phosphorylated mutagenic primers used for constructing the 
mutants are listed in the Supplementary Table S4. After confirming the success of the mutagenesis reactions, the 
mutant plasmids were transformed to E. coli α-select cells and MIC of the transformants were determined using 
the agar dilution method.
Sub‑cloning of ddl6 and ddl7 into pHCMC05 and transformation into B. subtilis. The genes for 
Ddl6 and Ddl7 were amplified by PCR using the pGEM-TEasy vectors with the 2024-bp insert containing ddl6 
and ddl7 as template (see Supplementary Table S4 for primers used). The genes were cloned into BamHI and 
XbaI sites of pHCMC05 (E.coli-B. subtilis shuttle vector) using the primers TddlF and TddlR (Supplementary 
Table  S4). Chemically competent B. subtilis 168 cells were prepared and transformed with the recombinant 
pHCMC05 vectors using the method described by  Hardy58. Transformants were spread onto BHI plates sup-
plemented with 10 µg/mL of chloramphenicol and incubated at 37 °C for 16–18 h.
Cloning and expression of ddl6 and ddl7. The coding sequence of the genes for Ddl6 and Ddl7 (1032-
bp) were amplified and cloned into the BamHI and XhoI sites of pET28a vector (Novagen) using the primers 
TddlF and Tddl28aR (Supplementary Table S4). The recombinant plasmids were transformed into E. coli BL21 
(DE3) cells (New England Biolabs) and transformants were selected on LB agar supplemented with kanamycin 
(30 µg/mL). 1L LB was inoculated with 10 ml overnight culture, and expression was induced in exponential 
growth phase by addition of 0.5 mM isopropyl β-d-1-thiogalactopyranoside for 3 h at 37 °C. Cells were har-
vested by centrifugation at 15,000×g at 4 °C and stored at − 20 °C until protein purification.
Purification of N‑ and C‑terminal His‑tagged Ddl6 and Ddl7 proteins by FPLC. Preserved cells 
were thawed on ice for 30 min and resuspended in buffer A (50 mM  NaH2PO4, 300 mM NaCl, 10 mM imidazole, 
pH 7.4) containing cOmplete EDTA-free protein inhibitor cocktail (Roche, 1 tablet/10 mL), lysozyme (1.0 mg/
mL) and DNAse (1 U/µL). The suspension was incubated on ice for 30 min and sonicated (6 pulse, each 10 s). 
Cellular debris was removed by centrifugation at 15,000×g for 30 min at 4 °C. Recombinant, N-and C-terminally 
His-tagged proteins were purified using a Ni–NTA Superflow cartridge (1 mL, Qiagen) and the Fast Protein 
Liquid Chromatography (FPLC) system (BioRad). The proteins were eluted with filter sterilized buffer B (50 mM 
 NaH2PO4, 300 mM NaCl, 250 mM imidazole, pH 7.4). Protein concentration was determined using Pierce BCA 
Protein Assay Kit (ThermoFisher Scientific) and purity was checked by sodium-dodecyl sulphate polyacryla-
mide gel electrophoresis (SDS-PAGE). The gels were stained with Coomassie Blue (BioRad) and destained with 
destaining reagent (10% acetic acid and 20% methanol).
Enzymatic activity assay. The d-ala-d-ala ligase activity of purified Ddl enzymes was assayed as described 
previously with some  modifications59,60: (1) Formation of d-ala-d-ala dipeptide: The reaction mixture contain-
ing the following components were incubated for 4 h at 37 °C: 50 mM Tris–HCl, 10 mM MgCl2, 10 mM KCl, 
20 mM d-alanine, 2 mM ATP, 2.5 mM Glutathione and 20 µg/mL of purified Ddl. To stop the reaction, the 
mixtures were boiled for 5 min at 95 °C. To determine the substrate specificity, an equimolar amount of D-Ser or 
d-Lac was substituted with d-Ala. Next, 4 µL of the reactions were loaded onto cellulose chromatography paper 
(Whatman) and ascending chromatography was developed for 3 h in butanol-acetic acid–water (12:3:5 vol/vol/
vol) containing 1.0% ninhydrin. The paper was dried for 5 min at 95 °C. d-ala-d-ala dipeptide formation in the 
reaction catalysed by Ddl was identified by comparison with commercially available d-ala-d-ala (Sigma). (2) 
Measurement of inorganic phosphate in the Ddl-catalysed reaction: The enzymatic activity of Ddl was also assayed 
by measuring the release of inorganic phosphate in the reaction (similar to the d-ala-d-ala dipeptide formation 
assay) with EnzChek phosphate assay kit (Life Technologies). 10 µL of the reaction product was added to 790 µL 
of standard reaction mixture containing 230 µL  dH2O, 50 µL 20X reaction buffer, 200 µL 2-amino-6-mercapto-
7-methylpurine riboside (MESG) substrate solution and 10 µL purine nucleoside phosphorylase and incubated 
at 22 °C for 30 min. After incubation absorbance of the reactions was measured at 360 nm with a spectropho-
tometer (Ultrospec 2000, Pharmacia Biotech). The amount of inorganic phosphate released into the reactions 
was calculated from the standard curve of inorganic phosphate.
Kinetic analysis of Ddl6 and Ddl7, DdlAEc and DdlTd. The  Vmax and  Km, d-ala2 of Ddl6, Ddl7, DdlTd 
and DdlAEc were determined by using pyruvate kinase (PK)/lactate dehydrogenase (LDH)-coupled spectro-
photometric  system60,61.
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All assays were conducted at 37 °C in 96-well plate system using CLARIOstar (BMG Labtech, Germany) in 
200 µL reaction buffer. The assay mixture (200µL) contained 100 mM HEPES (pH 7.5), 10 mM  MgCl2, 10 mM 
KCl, 0.2 mM NADH, 6–10 U/mL PK, 9–14 U/mL LDH, 2 mM phosphoenolpyruvate (PEP) and variable con-
centrations of ATP and D-alanine (saturating concentrations were 500 µM and 100 mM for ATP and d-alanine, 
respectively). The reactions were initiated by adding Ddl enzymes at a final concentration of 0.0025 µg/µL. The 
initial velocity  (v0) of the reactions was determined by measuring the changes in the absorbance at 340 nm for 
500 s (8.3 min). The slope of the reaction progression curves (time (s) vs change in absorbance at 340 nm) is 
equivalent to the  v0  (v0 = slope = ∆Y/∆X)62. The slope was calculated by the MARS data analysis software (BMG 
Labtech, Germany). After the  v0 values for each substrate concentration (ATP and D-alanine) were obtained, 
GraphPad Prism version 7 (GraphPad Software, Inc., USA) was used to determine the  Vmax and  Km values by 
fitting the curves for Michaelis–Menten model.
The values for  Km,ATP of different Ddls were determined at a fixed saturating concentration of d-alanine 
(100 mM) and varying concentrations of ATP starting from 5 µM to 320 µM. The  Km values for second d-alanine 
binding  (Km,d-ala2) was determined by using a fixed saturating concentration of ATP (500 µM; approximately 10 
times of  Km,ATP). The values of  Kcat  (s−1) for all enzymes were determined by dividing the Vmax (µM/s) with the 
concentration of enzymes, [E] (µM).
Phylogenetic analysis. The phylogenetic tree was constructed using MEGA X  software19. The sequences 
of Ddl6 and Ddl7 and their homologs were aligned with Clustal Omega. The default settings for Neighbour-
Joining method in MEGA X were applied to construct the phylogenetic tree.
Homology modelling of Ddl6 and Ddl7. The homology models of Ddl6 and Ddl7 were constructed 
using I-Tasser server (https ://zhang lab.ccmb.med.umich .edu/I-TASSE R)22. The amino acid sequences were sub-
mitted to the server and among the top five models built by the server, model 1 was selected based on the highest 
C-score and TM-score. A higher value of C-score signifies a model with a high confidence. A TM-score > 0.5 
indicates a model of correct topology and a TM-score < 0.17 means a random  similarity63. Models were visu-
alised with PyMOL (The PyMOL Molecular Graphics System, Version 1.8 Schrödinger, LLC). The homology 
models of Ddl6 and Ddl7 were matched with each other with the TM-align structural alignment program (https 
://zhang lab.ccmb.med.umich .edu/TM-align ) and the overlapped structures were evaluated with PyMOL.
Determination of minimum inhibitory concentrations (MIC):. The MIC of d-cycloserine, van-
comycin and beta-lactams were determined by agar dilution method following the guidelines of Clinical and 
Laboratory Standards Institute (CLSI) published in 2012. Three individual colonies of E. coli harbouring pET-
ddl6 or pET-ddl7 and B. subtilis 168 strains harbouring pHCMC05-ddl6 or pHCMC05-ddl7 were inoculated in 
Mueller–Hinton (MH) broth supplemented with appropriate antibiotics and cultured at 37 °C for 4–5 h and the 
 OD600 was adjusted to 0.08 to 0.1 using sterile saline. MH agar plates supplemented with various concentration 
of antibiotics starting from 0.125 to 256 µg/mL were prepared and inoculated with the adjusted bacterial suspen-
sions with a multipoint inoculator. The spots were allowed to dry for 30 min and the plates were then incubated 
aerobically at 37 °C for 16–20 h. The MIC value was defined as the lowest concentration of the inhibitory com-
pounds giving rise to no visible growth. MIC determinations were performed at least three times in triplicates. 
As a control, E. coli or B. subtilis 168 strains transformed with empty vectors were used.
Molecular docking. The predicted 3D-structures of Ddl6 and its two single mutants, L164F and W259C, as 
well as Ddl encoded by house-keeping gene of T. denticola (DdlTd) were used as the targets for molecular dock-
ing analyses. The 3D structure of Ddl6 was applied in PyMol program to generate L164F and W259C mutants. 
These protein targets were used for molecular docking of six ligands including d-alanine, d-cycloserine, ATP, 
apigenin, quercetin and salvicine, after minimisation and equilibration using AMBER program. AutoDock 
 SMINA64 was used to determine the best binding pocket by exploring all probable binding cavities in the pro-
teins. Then GOLD (Genetic Optimization for Ligand Docking)65,66 was used for docking the ligands into the 
SMINA-located binding site to perform flexible molecular docking analyses.
Genetic algorithm (GA) was used in GOLD ligand docking to thoroughly examine the ligand conformational 
flexibility along with partial flexibility of the  protein67. The maximum number of runs for the ligand was set to 
20 and in each run a population size of 100 with 100,000 operations was employed. The number of islands was 
5, and the niche size of 2 was considered. The default cut-off values of hydrogen bonds was set to 2.5 Å (dH-X), 
and for the van-der-Waals distance it was 4.0 Å. The GA docking was terminated when the top solutions attained 
the root mean square deviation (RMSD) values within 1.5 Å.
Molecular dynamics (MD) simulations. After molecular docking, the best poses of d-cycloserine in the 
d-Ala binding site of wild-type and W259C mutant of Ddl6 were selected as the starting structures to run MD 
simulations for 50 ns. The MD simulations were carried out using the AMBER 16.0 software  package68. The 
force fields parameters for D-cycloserine were generated using the ANTECHAMBER module of the AMBER 
programme. Each system was solvated using an octahedral box of TIP3P water molecules. Periodic bound-
ary conditions and particle-mesh Ewald (PME) method were employed in all the  simulations69. Particle-mesh 
Ewald method enabled us to calculate the ’infinite’ electrostatics without truncating the parameters. During each 
simulation, all bonds in which the hydrogen atom was present were considered fixed, and all other bonds were 
constrained to their equilibrium values by applying the SHAKE  algorithm70. A cutoff radius of 12 Å was used 
for the systems. Minimization was performed in two phases, and each phase was performed in two stages. In the 
first phase, ions and all water molecules were minimized for 1500 cycles of steepest descent followed by 1500 
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cycles of conjugate gradient minimization. Afterwards, the systems were minimized for a total of 5000 cycles 
without restraint wherein 2500 cycles of steepest descent were followed by 2500 cycles of conjugate gradient 
minimization. After minimizations, the systems were heated for 1000 ps while the temperature was raised from 0 
to 300 K, and then equilibration was performed without a restraint for 1000 ps while the temperature was kept at 
300 K. Sampling of reasonable configurations was conducted by running a 50 ns simulation with a 2 fs time step 
at 300 K and 1 atm pressure. A constant temperature was maintained by applying the Langevin algorithm while 
the pressure was controlled by the isotropic position scaling protocol used in AMBER 16 package  program68.
Statistical analysis. Statistical analysis was performed by using GraphPad Prism (GraphPad Software, Inc., 
USA; version 7.0). Statistical significance was calculated using one-way ANOVA. P values of ≤ 0.05 were consid-
ered statistically significant.
GenBank accession numbers. The sequences of the 2024 bp PCR amplicons containing ddl6 and ddl7 
were submitted separately to GenBank with the accession number of KU886208 and KU886209, respectively. 
The 4421 bp sequence of PCR product containing the upstream sequence of intI along with the downstream ddl7 
was submitted to GenBank with the accession number KY039278.
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